MoneyWorks4Me

AstraZeneca Pharma India board to consider financial results

27 Jul 2012 Evaluate
AstraZeneca Pharma India has informed that a meeting of the board of directors of the company will be held on August 10, 2012, to consider and approve the unaudited financial results of the company for the quarter ended June 30, 2012.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..